Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-migration HIV acquisition among african immigrants in the U.S.
Kerani RP, Lugg A, Berzins B, Gaye O, Lipira LE, Bundy C, Kwakwa H, Holmes KK, Golden MR. Kerani RP, et al. Among authors: berzins b. J Immigr Minor Health. 2022 Dec;24(6):1459-1468. doi: 10.1007/s10903-022-01356-2. Epub 2022 Apr 12. J Immigr Minor Health. 2022. PMID: 35415766 Free PMC article.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES; ACTIV-2/A5401 Study Team. Evering TH, et al. Ann Intern Med. 2023 May;176(5):658-666. doi: 10.7326/M22-3428. Epub 2023 Apr 18. Ann Intern Med. 2023. PMID: 37068272 Free PMC article. Clinical Trial.
No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study).
Kling KD, Janulis P, Demonbreun AR, Sancilio A, Berzins B, Krueger K, Achenbach C, Price R, Sullivan M, Caputo M, Hockney S, Zembower T, McDade TW, Taiwo B. Kling KD, et al. Among authors: berzins b. Front Immunol. 2023 Jan 9;13:1048776. doi: 10.3389/fimmu.2022.1048776. eCollection 2022. Front Immunol. 2023. PMID: 36700200 Free PMC article.
A randomized stepped wedge trial of an intensive combination approach to roll back the HIV epidemic in Nigerian adolescents: iCARE Nigeria treatment support protocol.
Taiwo BO, Kuhns LM, Omigbodun O, Awolude O, Kuti KM, Adetunji A, Berzins B, Janulis P, Akanmu S, Agbaji O, David AN, Akinbami A, Adekambi AF, Johnson AK, Okonkwor O, Oladeji BD, Cervantes M, Adewumi OM, Kapogiannis B, Garofalo R. Taiwo BO, et al. Among authors: berzins b. PLoS One. 2023 Jul 7;18(7):e0274031. doi: 10.1371/journal.pone.0274031. eCollection 2023. PLoS One. 2023. PMID: 37418498 Free PMC article.
Neurocognition with maraviroc compared with tenofovir in HIV.
Robertson KR, Miyahara S, Lee A, Brown TT, Chan ES, Berzins B, Rusin D, Eron JJ, Taiwo BO; AIDS Clinical Trials Group (ACTG) 5303 team. Robertson KR, et al. Among authors: berzins b. AIDS. 2016 Sep 24;30(15):2315-21. doi: 10.1097/QAD.0000000000001189. AIDS. 2016. PMID: 27333088 Free PMC article. Clinical Trial.
64 results